With advancements in technology and research, therapeutic peptides are a promising treatment modality
with the potential to address unmet medical needs and improve patient outcomes.
To bring together experts to debate over new developments and discoveries in the field, Johnson & Johnson
is organizing an R&D Symposium on Therapeutic Peptides on Thursday, June 27th, in Beerse, Belgium.
This one-day symposium will focus on exciting advances in discovering and developing therapeutic peptides.
Our invited speakers are experts from academia and industry, who will discuss peptide synthesis,
new advances in oral delivery and cell permeability, success stories, and future perspectives:
• Andreas Bernkop-Schürch, University of Innsbruck, Austria
• Christian Heinis, EPFL, Switzerland
• Dani Schultz, Merck, USA
• Kyungbo Kim, BioMedX Institute, Germany
• Pius Baur, Johnson & Johnson, Switzerland
• Steven Ballet, VUB Brussels, Belgium
• Vijaya Pattabiraman, Bright peak, Switzerland
• Gemma Mudd, Bicycle Therapeutics, UK
Click here to explore the program.
When?
Thu June 27th, 2024, from 8.30 AM to 5 PM
Where?
Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium
For Who?
Researchers, clinicians, and industry leaders active in the therapeutic peptide space
Registration is free, but seats are limited.
So be sure to secure your spot.
Don’t hesitate to contact Carina Oelbrandt at coelbran@its.jnj.com with any questions related to this event.